We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+42.2%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$865M
AUM Growth
Cap. Flow
+$807M
Cap. Flow %
93.21%
Top 10 Hldgs %
19.02%
Holding
1,207
New
1,203
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 12.54%
2 Healthcare 12.38%
3 Financials 11.94%
4 Consumer Discretionary 11.41%
5 Communication Services 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRFS
951
DELISTED
BRF SA
BRFS
$70K 0.01%
+17,528
New +$67.6K
ENVB icon
952
Enveric Biosciences
ENVB
$6.2M
$70K 0.01%
+1
New +$47.3K
DOMH icon
953
Dominari Holdings
DOMH
$63.8M
$69K 0.01%
+4,960
New +$62K
FBP icon
954
First Bancorp
FBP
$4.42B
$69K 0.01%
+12,266
New +$66.5K
QCLS
955
Q/C Technologies Inc
QCLS
$22.1M
$69K 0.01%
+3
New +$65K
NAVB
956
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$69K 0.01%
+17,586
New +$33.6K
BPT
957
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
$68K 0.01%
+20,474
New +$86.4K
LCTX icon
958
Lineage Cell Therapeutics
LCTX
$286M
$68K 0.01%
+78,042
New +$68.7K
OFS icon
959
OFS Capital
OFS
$48.8M
$68K 0.01%
+15,106
New +$70.3K
RIGL icon
960
Rigel Pharmaceuticals
RIGL
$778M
$67K 0.01%
+3,654
New +$65.7K
RDGT
961
Ridgetech Inc
RDGT
$3.59M
$67K 0.01%
+1
New +$76K
CANG
962
Cango Inc
CANG
$67.7M
$66K 0.01%
+1,087
New +$55.1K
IGC icon
963
IGC Pharma
IGC
$27.9M
$66K 0.01%
+109,493
New +$59.4K
CDMO
964
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$66K 0.01%
+10,055
New +$56.1K
ENG
965
DELISTED
ENGlobal Corp
ENG
$66K 0.01%
+8,045
New +$62.7K
FET icon
966
Forum Energy Technologies
FET
$882M
$65K 0.01%
+6,148
New +$49.3K
RFIL icon
967
RF Industries
RFIL
$135M
$65K 0.01%
+13,881
New +$70.5K
NSL
968
DELISTED
NUVEEN SENIOR INCM FD
NSL
$65K 0.01%
+13,844
New +$63.2K
ACET icon
969
Adicet Bio
ACET
$75.9M
$64K 0.01%
+264
New +$51.9K
YTEN
970
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$64K 0.01%
+427
New +$58.2K
VRAY
971
DELISTED
ViewRay, Inc.
VRAY
$64K 0.01%
+28,769
New +$61.4K
AGTC
972
DELISTED
Applied Genetic Technologies Corporation
AGTC
$64K 0.01%
+11,499
New +$52.7K
ASX icon
973
ASE Group
ASX
$82.7B
$63K 0.01%
+13,808
New +$58.9K
AVXL icon
974
Anavex Life Sciences
AVXL
$314M
$63K 0.01%
+12,903
New +$48.8K
CAN
975
Canaan Creative
CAN
$149M
$63K 0.01%
+33,353
New +$117K

Similar funds

Virtu Financial's Q2 2020 Portfolio in Review

Q2 2020 is the first quarter with a 13F filing on record for Virtu Financial, which disclosed 1,207 positions worth $865M. Its ten largest holdings account for 19% of the portfolio.

Its largest position is Vanguard S&P 500 ETF: 156,256 shares worth $44.3M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, followed by Healthcare and Financials.

  • Virtu Financial's largest Q2 2020 buy was Vanguard S&P 500 ETF: 156,256 shares worth $44.3M.
  • Virtu Financial's ten largest holdings make up 19% of its $865M portfolio in Q2 2020.
  • Virtu Financial disclosed 1,207 positions in Q2 2020, its first 13F filing on record.

Based on Virtu Financial's 13F filing for Q2 2020, filed 7 Aug 2020.